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BiomarkerIdentiﬁcation of markers of abnormal brain function in children at-risk of schizophrenia may inform early in-
tervention and prevention programs. Individuals with schizophrenia are characterised by attenuation of
MMN amplitude, which indexes automatic auditory sensory processing. The current aim was to examine
whether children who may be at increased risk of schizophrenia due to their presenting multiple putative an-
tecedents of schizophrenia (ASz) are similarly characterised by MMN amplitude reductions, relative to typi-
cally developing (TD) children. EEG was recorded from 22 ASz and 24 TD children aged 9 to 12 years
(matched on age, sex, and IQ) during a passive auditory oddball task (15% duration deviant). ASz children
were those presenting: (1) speech and/or motor development lags/problems; (2) social, emotional, or behav-
ioural problems in the clinical range; and (3) psychotic-like experiences. TD children presented no anteced-
ents, and had no family history of a schizophrenia spectrum disorder. MMN amplitude, but not latency, was
signiﬁcantly greater at frontal sites in the ASz group than in the TD group. Although the MMN exhibited by
the children at risk of schizophrenia was unlike that of their typically developing peers, it also differed
from the reduced MMN amplitude observed in adults with schizophrenia. This may reﬂect developmental
and disease effects in a pre-prodromal phase of psychosis onset. Longitudinal follow-up is necessary to estab-
lish the developmental trajectory of MMN in at-risk children.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Schizophrenia is a neurodevelopmental disorder with onset occur-
ring typically during late adolescence or early adulthood (Murray and
Lewis, 1987;Weinberger, 1987). Premorbidly, childrenwho later devel-
op the illness exhibit a developmental trajectory that is subtly distinct
from their healthy counterparts (Welham et al., 2009b). These putative
developmental antecedents of schizophrenia,which are present already
by age 12 years, include motor dysfunctions, lower IQ and poorer aca-
demic achievement, disturbances in social, emotional, and behavioural
functioning, and subclinical psychotic-like experiences (Kaymaz et al.,
2012; Matheson et al., 2011; Welham et al., 2009a). Such antecedents
might reﬂect early passive expression of the disorder or may actively
modify risk within the aetiological pathway (Matheson et al., 2011).
The identiﬁcation of salient biological and developmental indices ofity of New SouthWales, Sydney,
aurens).
.V. Open access under CC BY-NC-ND lischizophrenia risk in children and adolescents may facilitate early de-
tection and inform early intervention and prevention programs
(Laurens et al., 2007; Matheson et al., 2011). We previously developed
a questionnaire-based community screening method for identify-
ing children aged 9–12 years whomay be at elevated risk for the devel-
opment of schizophrenia by virtue of presenting multiple putative
antecedents of the disorder, namely: (i) speech and/or motor develop-
mental delays or abnormalities, (ii) social, emotional, and/or behaviour-
al problems, and (iii) psychotic-like experiences (Laurens et al., 2007,
2008, 2011). Only longitudinal follow-up of these children can deter-
mine the speciﬁcity and sensitivity with which this triad of antecedents
predicts later schizophrenia relative to other psychiatric disorders, or to
no disorder. Nevertheless, preliminary evidence gathered from children
presenting the antecedent triad indicates that, relative to their typically
developing (TD) peers, these children are characterised by abnormali-
ties that are present among adults with schizophrenia, including func-
tional brain abnormality following commission of behavioural errors
(Laurens et al., 2010), involuntary dyskinetic movement abnormalities
(MacManus et al., 2012), and structural brain abnormalities in the tem-
poral lobes (Cullen et al., in press). Compared to TD children, children
presenting antecedents of schizophrenia (ASz) also show poorer intel-
lectual and cognitive functioning (Cullen et al., 2010), elevated socialcense.
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tion recognition (Dickson et al., in press).
A reduction in the amplitude of the mismatch negativity (MMN),
an event related potential (ERP) component that indexes the brain re-
sponse to auditory change detection (i.e., an automatic process that
detects a difference between an incoming stimulus and the sensory
memory trace of preceding stimuli), may represent another candidate
biomarker (or endophenotype) indexing an increased risk for the
development of schizophrenia (Moghaddam and Javitt, 2012). The
identiﬁcation of potential endophenotypes of schizophrenia is impor-
tant because valid endophenotypes offer objective and cost-effective
methods of laboratory screening and subtyping (Light et al., 2012;
Luck et al., 2011). They can be employed in the development of
novel targeted schizophrenia treatments and in the measurement of
treatment outcomes. In research, they can provide insights into dis-
ease chronicity and inform our understanding of the relationship
between genetic variability and the clinical expression of the disease
(Light et al., 2012; Luck et al., 2011). In healthy adults, the MMN is
typically observed as a fronto-central negativity of ~0.5–5 μV in
amplitude, elicited in the latency range ~100–250 ms, with temporal
and frontal generators (Duncan et al., 2009; Giard et al., 1990). In
adults with schizophrenia, MMN amplitude correlates with disease
severity (e.g., cognitive decline, negative symptoms), functional out-
come, and fronto-temporal grey matter volume loss (Green et al.,
2009; Light and Braff, 2005; Naatanen et al., 2011; Umbricht and
Krljes, 2005). Relative to healthy controls, adults with chronic schizo-
phrenia are characterised by attenuation of MMN amplitude at frontal
and temporal scalp regions, but no signiﬁcant latency differences
(Michie, 2001; Michie et al., 2008; Naatanen and Kahkonen, 2009;
Turetsky et al., 2007). This is a robust effect with a large mean effect
size (0.99) and good test–retest reliability (Turetsky et al., 2007;
Umbricht and Krljes, 2005). It is observed in medicated and
medication-naive patients alike, and it can persist in spite of changes
to medication (Todd et al., 2012).
The MMN also appears sensitive to disease state. For example,
Shinozaki et al. (2002) measured the MMN at acute- and post-acute
phases in patients with a retest interval of 1 to 13 months. They found
anMMN reduction in 13 schizophrenia patients compared to 13healthy
controls, and this reduction was greater at the mastoidal MMN for pa-
tients during the acute phase than the post-acute phase. However, no
signiﬁcant schizophrenia phase-related differences were obtained at
the Fz electrode.
In regard to the early stages of schizophrenia, there is some in-
dication of a reduced MMN in ﬁrst-episode schizophrenia patients
compared to chronic patients and/or healthy controls (e.g., Hermens
et al., 2010; Kaur et al., 2011). However, there are also incompatible
ﬁndings; that is, of signiﬁcant differences in MMN amplitude between
groups of ﬁrst-episode patients and healthy controls (e.g., Magno
et al., 2008; Salisbury et al., 2002). Apparent inconsistencies in the
MMN literature concerning the early stages of schizophrenia and
at-risk groups may be in part due differences in the type of auditory
deviants employed (e.g., duration, frequency, intensity, pitch). Al-
though the elicited MMNs are ostensibly similar in morphology, they
may have distinct neuronal origins in the frontal and temporal cortices
(Belger et al., 2012). The duration deviant elicits themost robustMMN
amplitude reduction in studies of schizophrenia (Belger et al., 2012;
Umbricht and Krljes, 2005).
A number of studies have examined theMMN in groups purportedly
at risk for developing schizophrenia using a variety of measures. For ex-
ample, Shin et al. (2009) selected a sample of 16 ultra-high-risk (UHR)
adults on the basis of reported attenuated psychotic symptoms, brief
limited intermittent psychotic symptoms, and trait and state risk factors
for a magnetoencephalographic (MEG) study. They found a reduced
MMN dipole moment compared to the healthy age-matched controls.
Their follow-upMEG study revealed a similar MMN dipole moment re-
duction in UHR adults and schizophrenia patients, relative to thehealthy controls (Shin et al., 2012). Comparable ﬁndings of anMMN re-
duction in UHR groups in electroencephalographic (EEG) data have
been reported (Atkinson et al., 2012; Schreiber et al., 1992; Stone et
al., 2010). There is also evidence of the MMN reduction among prodro-
mal individuals (Bodatsch et al., 2011; Brockhaus-Dumke et al., 2005),
which arguably provides the strongest support for the use of the
MMN as biomarker of schizophrenia risk.
In light of theseﬁndings, the current aimwas to evaluate theMMNas
a potential biomarker of risk for schizophrenia in putatively at-risk chil-
drenwhopresentedmultiple putative antecedents of schizophrenia.We
hypothesised that ASz children would be similarly characterised by the
MMN reduction observed in adults with chronic schizophrenia, relative
to TD low-risk control children.
2. Methods
The present MMN data were acquired during the initial phase of a
larger prospective longitudinal study of children. Only the methodol-
ogy relevant to the investigation of MMN is described here. Ethical
permission for the study was granted by the Joint South London and
Maudsley and the Institute of Psychiatry Research Ethics Committee.
Caregivers and children provided written informed consent and as-
sent, respectively, for participation.
2.1. Participants
Participants for this study were identiﬁed from the community
using a school-based questionnaire screening procedure, which has
been described in detail previously (Laurens et al., 2007, 2008,
2012). A community sample of 618 children (aged 9 to 12 years)
and their respective primary caregivers completed questionnaires.
The child questionnaire comprised the 25-item Strengths and
Difﬁculties Questionnaire (SDQ) (Goodman, 2001), and nine items
assessing psychotic-like experiences (PLEs) (Laurens et al., 2012).
Caregiver questionnaires included quantitative and qualitative mea-
sures of developmental delays or abnormalities in speech and motor
function (9 items), the parent-report SDQ, parent-report PLE items,
and socio-demographic information and family history of health
problems (Laurens et al., 2007).
ASz children were deﬁned as those presenting a triad of replicated
antecedents of schizophrenia, comprising: 1) a caregiver-reported
delay or abnormality in speech and/or motor development; 2) an
“abnormal” rating (i.e., approximately top tenth percentile of UK popu-
lation norms) on at least one SDQ psychopathology scale (i.e., child-
reported emotional symptoms, or caregiver-reported conduct prob-
lems, hyperactivity-inattention, or peer relationship problems); and 3)
child-reported “certain experience” of at least one PLE (Laurens et al.,
2007, 2008). TD children were those who presented none of the ante-
cedents on questionnaire, and whose caregivers reported no family
history of schizophrenia spectrum illness in any ﬁrst-, second-, and
third-degree relatives (conﬁrmed subsequently via caregiver-report
on the Family Interview for Genetic Studies (Maxwell, 1992)). None of
the children had ever taken psychotropic medication. Exclusion criteria
for both groups were a previous psychotic episode, neurological disor-
der (e.g., epilepsy), autism or Asperger's disorder, learning difﬁculties
(IQ b 70), and insufﬁcient ability in English language to complete inter-
views or questionnaires. The percentage of childrenmeetingASz and TD
criteria in the community sample was 9% and 23% respectively. For this
study, we invited 48 ASz and 47 TD children to complete a battery of as-
sessments including ERP recordings, amongwhom 26 ASz (54%) and 24
TD (51%) subsequently provided MMN data for analysis.
2.2. Stimuli and procedure
The MMN recording session was completed as part of a larger
battery of assessments that also measured intelligence (Wechsler
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ment status (Pubertal Development Scale (Carskadon and Acebo,
1993)), handedness (Annett Hand Preference Questionnaire (Annett,
1970)), and socio-economic status (UK National Statistics Socio-
economic Classiﬁcation (Ofﬁce of Population Censuses and Surveys,
1980)). Diagnostic interviews were completed by clinicians with the
child's parent using the Kiddie Schedule for Affective Disorders and
Schizophrenia Present and Lifetime version (Kaufman et al., 2000).
Stimuli for the MMN task were 1600 tones at 1000 Hz, including
1360 (85%) standards of 25 ms duration and 240 (15%) deviants of
50 ms duration, all with a rise and fall time of 5 ms. These were
presented binaurally at 80 dB via Sennheiser HD-215 earphones in
four blocks of 400 tones (comprising 340 standards and 60 deviants
each), in a pseudorandom order so that the deviants were separated
by at least one standard. The stimulus onset asynchrony was 325 ms
for each standard and 350 ms for each deviant, which yielded an iso-
chronous interstimulus interval of 300 ms. The four blocks were sepa-
rated by a rest period, the duration of which was determined by the
participant. Participants were instructed to ﬁxate on a cross that was
presented in the centre of a PC display screen throughout the task.
2.3. Electrophysiological recording
Electrocortical data were recorded from 30 Ag/AgCl sintered elec-
trodes, arranged according to the international 10–10 system, and
referenced to the nose tip. Only data from fronto-central electrodes
(i.e., F3, Fz, F4, FC3, FCz, FC4, C3, Cz, C4) are reported here, as the
MMN has a characteristic fronto-central predominance. Horizontal
and vertical electro-oculograms were recorded from tin electrodes po-
sitioned adjacent to the outer canthus of each eye, and above and
below the left eye, respectively. The electrical impedance of each elec-
trode was maintained at less than 10 kilo-ohms. These data were ac-
quired continuously via NeuroScan SynAmps hardware with Scan 4.3
software (Compumedics, Charlotte, North Carolina). The sampling rate
was 500 Hz, with a gain of 500, and band-pass ﬁltering at .05 to 100 Hz.
2.4. ERP data processing
The EEG data were processed ofﬂine using Brain Vision Analyzer
software (Brain Products, Gilching, Germany). The investigators
were blind to group status during EEG data processing and extraction
of MMN component peak amplitude and latency data, with the data
subsequently un-blinded for group analyses of these indices. EEG ﬁl-
tering entailed a 0.5 Hz high-pass and 25 Hz low-pass zero-phase
Butterworth ﬁlters with a 24 dB/octave slope, as well as a 50 HzTable 1
Demographic characteristics of the children presenting putative antecedents of schizophren
Demographic variable ASz (n = 26
n
Age (on day of ERP recording)
Pubertal development scale scorea
IQ (full-scale estimate)b
Time-lapse between assessment of antecedents and ERP recording
Sex (male/female) 18/8
Handedness (right-dominant/mixed or left-dominant) 19/7
Ethnicityc (white British/white other/black African or African-Caribbean
or mixed white-black African or African-Caribbean/other)
6/5/7/8
Socio-economic status based on occupationd (professional/managerial
and technical/skilled-non-manual/skilled-manual)
3/11/6/5
Notes: ERP = event-related potential; y = years, m = months.
a Pubertal development scale total score is created as the average of scores obtained on 5
development (a score of 2 indicates an “Early Pubertal” stage; (Carskadon and Acebo, 1993
b Full-scale IQ estimate derived from the four subtests (two verbal, two performance)
(Wechsler, 1999).
c “Other” included white European (n = 5), Latin American (n = 2), Bangladeshi (n =
d Socio-economic status was coded according to four classes: (i) professional occupation
(vi) skilled-manual occupations.notch ﬁlter. The resultant EEG was corrected for ocular artefact
using the method of Gratton et al. (1983), and then segmented into
1360 standard, and 240 deviant, stimulus-locked epochs of 600 ms
duration (100 ms pre-stimulus to 500 ms post-stimulus). All epochs
were baseline-corrected to the 100 ms pre-stimulus epoch. Single tri-
als contaminated by muscular activity or ampliﬁer blocking were ex-
cluded. Single trials with voltages exceeding ±50 μV at any electrode
were excluded. Accepted epochs were averaged to produce individual
participant waveforms for standards and deviants, and MMN differ-
ence waveforms (subtracting standard from deviant waves) were
then computed. Choice of latency window for peak MMN component
detection in the grand mean difference waveforms was informed by
previous studies of adults with schizophrenia that employed a similar
MMN administration protocol (Bramon et al., 2004; Hall et al., 2006),
and by visual inspection of waveforms (blind to group status). The
MMN was deﬁned as the largest negative peak occurring in the
range of 75 to 200 ms post-stimulus, which accommodated the indi-
vidual variability in MMN peak latency that is typical of children rel-
ative to adults (Cheour et al., 2000).
2.5. Statistical analysis
Univariate ANOVAs were used to analyse group differences in con-
tinuous demographic variables, including age, pubertal development
status, IQ, and time-lapsed between assessment of antecedents and
MMN recording. Chi-square and Fisher's Exact tests were employed
in the case of categorical demographic variables, including sex, hand-
edness, ethnicity, and social class.
Amplitude and latency data were analysed separately in regard to
the standard, deviant, and MMN difference waveforms using repeated-
measures ANOVAs, with a between-subjects factor of group (ASz, TD),
and within-subjects factors of anterior–posterior (Frontal, Fronto-
Central, Central) and lateral (Midline, Left, Right) topography. Green-
house–Geisser correction was employed with the repeated-measures
ANOVAs, and Bonferroni correction for multiple comparisons was ap-
plied in post-hoc tests of simple main effects.
3. Results
3.1. Demographic and IQ data
As indicated in Table 1, there were no signiﬁcant differences be-
tween the ASz and TD groups on demographic variables, pubertal de-
velopment status, or estimated IQ.ia (ASz) and the typically developing (TD) children.
) TD (n = 24) Statistical test
Mean (SD) n Mean (SD)
11 y (12 m) 11 y (10 m) F(1,48) = .1, p = .9
2.4 (1.3) 1.9 (0.9) F(1,48) = 3.2, p = .1
105 (12) 111 (15) F(1,48) = 2.8, p = .1
8 m (6 m) 9 m (6 m) F(1,48) = .5, p = .5
14/10 χ2 = .6, df = 1, p = .4
20/4 χ2 = .8, df = 1, p = .4
11/6/5/2 p = .2, Fisher's Exact Test
2/16/3/2 p = .4, Fisher's Exact Test
indices of pubertal status (range 1–5); higher scores indicate more advanced pubertal
)).
and the U.S. normative data comprising the Wechsler Abbreviated Scale of Intelligence
1), and mixed (n = 3) ethnicity.
s, (ii) managerial and technical occupations, (iii) skilled non-manual occupations, and
Fig. 2. Signiﬁcant group difference in MMN peak amplitude at frontal sites in children
presenting antecedents of schizophrenia (ASz) and typically developing children (TD).
Error bars denote standard error.
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least one ‘certainly true’ PLE response (16 reported two or more expe-
riences), experienced delays or abnormalities in speech and/or motor
development (23 had speech and 7 had motor delays/abnormalities;
including 4 children who presented both), and a social, emotional, or
behavioural problem on the SDQ (6 had emotional symptoms at abnor-
mal level, 13 had conduct problems, 11 had hyperactivity-inattention,
and 13 had peer relationship problems). Two ASz children also had a
family history of schizophrenia. Diagnostic interviews by clinicians
(Kaufman et al., 2000) indicated that three ASz children met diagnos-
tic criteria for attention-deﬁcit hyperactivity disorder (ADHD) and
four ASz children met criteria for oppositional deﬁant/conduct disor-
ders (including two with comorbid ADHD and oppositional/conduct
disorders). No child met diagnostic thresholds for anxiety or depres-
sive disorders.
3.2. Electrophysiological data
No child in the study had fewer than 89 epochs (37%) contributing to
themeandeviantwaveforms. On average, thenumber of includedepochs
was not signiﬁcantly different between the ASz (167.83 ± 37.27;
mean ± SD) and TD (186.75 ± 31.27; mean ± SD) groups.
Fig. 1 illustrates the grand meanMMNwaveforms for each group at
the nine scalp electrodes. No signiﬁcant group differences (main effects
or interactions) in MMN peak latency were found. In terms of MMN
peak amplitude, a signiﬁcant anterior–posterior-by-group interaction
was observed (F(1.6,75.2) = 4.31, p = .025). Therewere no signiﬁcant
main effects or interactions involving laterality.FC3 FCz
C3 Cz
Fig. 1. Grand mean waveforms for the nine frontal, fronto-central, and central sites in childre
dren (solid line).Follow-up analysis indicated signiﬁcantly greater overall frontal
MMN peak amplitude for the ASz group than the TD group (F(1,48) =
5.67, p = .021), as shown in Fig. 2. A summary of the group means for
MMN peak amplitudes and their standard errors is available in Supple-
mentary Table 1, and a corresponding summary for latency is available
in Supplementary Table 2.
Additional analyses were performed separately on the standard and
deviant waveforms (see Supplementary Figs. 1 and 2) in order toF4
FC4
C4
n presenting antecedents of schizophrenia (hashed line) and typically developing chil-
Fig. 3. Signiﬁcant group difference in mean deviant amplitude at frontal sites in chil-
dren presenting antecedents of schizophrenia (ASz) and typically developing children
(TD). Error bars denote standard error.
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ferencewave. Therewere no signiﬁcant group differences in the latency
of either the standard or deviant waveforms, or in the amplitude of the
standard waveforms. However, a signiﬁcant anterior–posterior-by-
group interaction was evident in deviant waveforms (F(1.2,57.5) =
3.84, p = .048). The overall frontal amplitude of the deviant waveform
was greater for the ASz compared to the TD group (F(1,48) = 4.25, p =
.045); see Fig. 3.
4. Discussion
We observed an MMN increase in children purportedly at risk of
schizophrenia (i.e., greater frontal MMN amplitude in the ASz children
than the TD children). This MMN amplitude difference primarily
reﬂected the response to the deviant stimuli, which elicited a larger
frontal MNN for ASz than TD children. It was anticipated that the
MMN effect observed in the ASz children would resemble that com-
monly found in adults with chronic schizophrenia. However, it is mark-
edly different because it consists of anMMN amplitude increase, rather
than a decrease (see reviews; Michie, 2001; Michie et al., 2008;
Naatanen and Kahkonen, 2009; Turetsky et al., 2007). This effect is
also incompatible with ﬁndings from other studies of at risk groups (in-
cluding prodromal patients), which generally also show a reduction in
MMN amplitude, albeit of smaller magnitude than in chronic schizo-
phrenia (Atkinson et al., 2012; Bodatsch et al., 2011; Brockhaus-
Dumke et al., 2005; Schreiber et al., 1992; Stone et al., 2010). Further,
the observed MMN topography has a frontal maximum instead of the
characteristic fronto-centralmaximum (Duncan et al., 2009).
The existing MMN schizophrenia literature offers no obvious expla-
nation for the relatively increased frontal MMN observed in the ASz
children. However, brain volume data that we obtained in an
overlapping, though not identical, sample of children may help inter-
pret the MMN effect (Cullen et al., in press). In that study, voxel-based
morphometry analysis was used to compare grey matter (GM) and
white matter (WM) volumes between groups of 20 ASz and 20 TD chil-
dren. The ASz children were characterised by signiﬁcantly reduced GM
in the right temporal lobe, as well as signiﬁcantly increased GM and
WM in the left temporal lobe, relative to the TD children. Temporal
GM volume loss is a common ﬁnding in chronic schizophrenia, and cor-
relates with MMN amplitude reduction (Rasser et al., 2011). Although
speculative, it is conceivable that the relative increase in left temporal
GM and WM volume may contribute to the relative MMN amplitude
increment observed in the ASz group. The amplitude of the MMN
reﬂects the contributions of its generators, which are located in the
auditory and frontal cortices (Naatanen and Kahkonen, 2009). Hence,
the observed MMN increment may reﬂect the underlying structuralabnormalities evident in the temporal lobes of ASz children, speciﬁcally
increased left temporal GM and WM volumes. Further research is re-
quired to test this hypothesis.
It is possible that theseMMN and structural peculiarities in the ASz
children are the product of maturational and disease processes.
Most of the children in the sample were in an early pubertal stage of
development at the time of MMN recording. Maturational changes
are reﬂected in MMN amplitude, latency, and scalp topography.
Although inter-individual variability in the MMN is high during matu-
ration (Cheour et al., 2000), there is evidence that healthy young chil-
dren generally exhibit larger MMN amplitudes and longer latencies
compared to adults (Cheour et al., 2000; Dunn et al., 2008; Gomot et
al., 2000). These differences decline with maturation, and the MMN
typically becomes comparable to that of adults in late childhood
(Cheour et al., 2000). The topography of the MMN also changes con-
siderably during development—it is generally central in young chil-
dren, whereas it is more fronto-central in adults (Cheour et al., 2000;
Dunn et al., 2008; Martin et al., 2003), possibly reﬂecting underlying
maturational processes in the frontal lobes. Frontal lobe changes oc-
curring during puberty have a major impact on the development of
cognition and attention. The frontal MMN component, which has
generators in the dorsolateral prefrontal cortex, is believed to index
involuntary attention switching (Naatanen et al., 2011; Segalowitz et
al., 2010). Considered in light of the developmental MMN literature,
and the brain structure abnormalities found in this cohort (Cullen et
al., in press), the current ﬁnding of greater frontal MMN amplitude
in the ASz children raises the possibility that the ASz children may
be undergoing a different developmental trajectory than their TD
peers, and that this trajectory may be pathological. Perhaps the en-
hanced frontal MMN is indicative of a delayed trajectory since the
MMN tends to be larger in young children.
Maturational changes to the excitatory/inhibitory balance of neuro-
transmitter systems and underlying brain structure associated with the
onset of puberty have been linked to the genesis of a number of psychi-
atric disorders, including schizophrenia (Lenroot and Giedd, 2010). Pu-
berty entails large-scale destabilisation and restructuring of the brain,
includingmyelination, synaptic pruning, and dopaminergic innervation
of the frontal lobes (Lenroot and Giedd, 2010; Segalowitz et al., 2010).
These changes signiﬁcantly alter communication between the fronto-
parietal and fronto-temporal networks (Segalowitz et al., 2010). Sex
steroid receptors predominate in the frontal lobes and pubertal hor-
mones alter neurotransmitter activity (Lenroot and Giedd, 2010). For
example, oestrogen acts upon the cholinergic, noradrenergic, serotoner-
gic, and hypothalamic dopaminergic systems, while oestradiol induces
formation of new excitatory synapses, which entails the activation of
N-methyl-D-aspartate (NMDA) receptors (McEwen, 2002). This has
particular relevance to current models of schizophrenia that postulate
NMDA receptor hypofunction as a core feature of the disease (Todd et
al., 2012). The MMN appears to be an effective index of NMDA system
integrity, as evidenced by pharmacological data from studies of humans
and animals (Javitt et al., 1996; Todd et al., 2012). It has been proposed
that the MMN reduction found in chronic schizophrenia may denote
central auditory dysfunction, possibly reﬂecting deﬁcient memory
trace formation due to NMDA receptor hypofunction (Naatanen and
Kahkonen, 2009; Naatanen et al., 2011).
In regard to the current ﬁndings, the ASz children are purportedly at
risk of schizophrenia, yet the frontal MMN increment in the ASz group is
ostensibly inconsistent with the well-established ﬁndings from adults
with chronic schizophrenia. However, some insights are available from
pharmacological studies that attempt to model cognitive deﬁcits and
neurotransmitter system dysfunction in schizophrenia by perturbing
the excitatory (glutamatergic) and inhibitory (GABAergic) neurotrans-
mitter systems in healthy adults. For example, Korostenskaja et al.
(2007) administered memantine, an NMDA receptor antagonist, to 13
healthy adults in order tomodel involuntary attention deﬁcits in schizo-
phrenia believed to be associated with NMDA receptor dysfunction.
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oddball task, was enhanced by memantine. This result is unusual be-
cause other NMDA receptor antagonists (e.g., ketamine) typically pro-
duce an MMN reduction (see review by Kenemans and Kahkonen,
2011). The authors suggested that their unexpected ﬁnding may reﬂect
the unique pharmacological properties of memantine (Korostenskaja et
al., 2007). Another study examined selective and involuntary attention
in 12 healthy adults after administration of haloperidol, a dopamine
D2 receptor antagonist, using a dichotic listening task. The results
showed that haloperidol enhanced frontal MMN amplitude and in-
voluntary attention, while impairing selective attention (Kahkonen et
al., 2001). Findings such as these demonstrate that perturbing the excit-
atory and inhibitory balance can produce a frontalMMN increment rem-
iniscent of that seen in the ASz children, which may be indicative of
pathology occurring during puberty. Further research is necessary to de-
termine the integrity of key neurotransmitter systems in the ASz group,
but at this stage, it is reasonable to speculate that the observedMMN ef-
fect is unlike that seen in the prodrome or in chronic schizophrenia be-
cause it reﬂects the complex interplay of developmental and disease
effects in a pre-prodromal phase of psychosis onset in children at risk
of developing schizophrenia.
Other, unmeasured factors, might explain the relative MMN in-
crease obtained in the ASz children relative to their typically develop-
ing peers. For example, Chobert et al. (in press) have demonstrated
MMN amplitude increases in children followingmusical training. Fail-
ure to assess such potential modiﬁers of the MMN in our sample is
likely to have contributed to the inter-individual variability observed
in our study.
Interpretation of the current data in terms of future developmen-
tal trajectories and pathology remains highly speculative without the
support of follow-up evidence of eventual progression to psychosis,
accompanied by the characteristic MMN decrement of chronic schizo-
phrenia. Accordingly, longitudinal follow-up is essential in order to
establish the developmental trajectory of MMN in at-risk children.
This will be addressed in ongoing follow-up assessments being com-
pleted in the children.
In sum, we found a relative increase in MMN amplitude in chil-
dren purportedly at risk of schizophrenia, which differed from the
MMN amplitude reduction typically found in adults with chronic
schizophrenia. This outcome may reﬂect developmental and disease
effects in a pre-prodromal phase of psychosis onset in children at
risk of developing schizophrenia. Hence, the MMN may have utility
as a biomarker for identifying children at risk of schizophrenia. Longi-
tudinal follow-up is necessary to delineate the nature of the develop-
mental trajectory of the MMN in at-risk children.Acknowledgements
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